Heterogeneity_of_T_cell_lymphoblastic_leukaemias._Twenty_eight_out_of_170_consecutive_cases_of_acute_lymphoblastic_leukaemia_(ALL)_were_examined._They_were_of_T_cell_origin,_with_the_following_distribution:_seven_(28%)_cases_had_pre-T_or_prothymic_features;_nine_(36%)_cases_showed_early_thymocytic_features,_six_(24%)_had_cortical_features;_and_three_(12%)_had_a_"mature"_phenotype._The_remaining_three_cases_could_not_be_sub-classified._A_striking_finding_was_that_pre-T_ALL_differed_from_intrathymic_ALL_not_only_in_the_absence_of_both_E_rosettes_and_intrathymic_differentiation_antigens,_but_also_in_the_expression_of_two_non-lineage_specific_antigens_HLA-DR_and_CD10._Both_antigens_appear_in_the_bone_marrow_from_the_very_first_stages_of_lymphoid_differentiation,_implying_that_the_origin_for_pre-T_ALL_is_bone_marrow._A_comparison_of_the_clinical_features_of_pre-T_and_thymic_ALL_showed_that_pre-T_ALL_disease_showed_a_pattern_more_similar_to_non-T_ALL_disease:_a_lower_incidence_of_mediastinal_mass,_absence_of_extrahaematopoietic_disease,_lower_white_cell_counts_and_haemoglobin_concentrations,_and_a_higher_incidence_of_bone_pain._No_obvious_difference_in_response_to_treatment_was_apparent._The_results_show_that_T-ALL_is_not_only_a_heterogeneous_immunological_group_but_also_suggest_that_it_may_have_different_origins:_bone_marrow_for_pre-T_ALL_and_the_thymus_for_thymic_ALL.